标题
Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era
作者
关键词
-
出版物
Cells
Volume 11, Issue 5, Pages 770
出版商
MDPI AG
发表日期
2022-02-23
DOI
10.3390/cells11050770
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Practice review: Evidence-based quality use of corticosteroids in the palliative care of patients with advanced cancer
- (2021) Janet Hardy et al. PALLIATIVE MEDICINE
- Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
- (2021) D. Miles et al. ANNALS OF ONCOLOGY
- Do Steroids Matter? A Retrospective Review of Premedication for Taxane Chemotherapy and Hypersensitivity Reactions
- (2021) Olivia M. Lansinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
- (2021) Jong-Mu Sun et al. LANCET
- Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events
- (2021) Jia Luo et al. Journal of Thoracic Oncology
- Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates
- (2021) Paolo Tarantino et al. JAMA Oncology
- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Steroids use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
- (2020) Fausto Petrelli et al. Cancers
- Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non–Small-Cell Lung Cancer
- (2020) Shirish Gadgeel et al. JOURNAL OF CLINICAL ONCOLOGY
- A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous Non–Small-Cell Lung Cancer: Protocol-Specified Final Analysis of KEYNOTE-407
- (2020) Luis Paz-Ares et al. Journal of Thoracic Oncology
- Endogenous Glucocorticoid Signaling Regulates CD8+ T Cell Differentiation and Development of Dysfunction in the Tumor Microenvironment
- (2020) Nandini Acharya et al. IMMUNITY
- Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial
- (2020) Thomas Powles et al. LANCET ONCOLOGY
- Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma
- (2020) J. Bryan Iorgulescu et al. CLINICAL CANCER RESEARCH
- How to manage patients with corticosteroids in oncology in the era of immunotherapy?
- (2020) Mihaela Aldea et al. EUROPEAN JOURNAL OF CANCER
- Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
- (2020) Javier Cortes et al. LANCET
- Glucocorticoids promote breast cancer metastasis
- (2019) Milan M. S. Obradović et al. NATURE
- Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
- (2019) John A. Thompson et al. Journal of the National Comprehensive Cancer Network
- Safety and efficacy of nivolumab in metastatic renal cell carcinoma (mRCC): Final analysis from the NIVOREN GETUG AFU 26 study.
- (2019) Laurence Albiges et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
- (2019) Leonie Voorwerk et al. NATURE MEDICINE
- Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis
- (2019) Hamzah Abu-Sbeih et al. Journal for ImmunoTherapy of Cancer
- Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program
- (2019) Elena Verzoni et al. Journal for ImmunoTherapy of Cancer
- Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities
- (2019) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- Cytotoxic Chemotherapy as an Immune Stimulus: A Molecular Perspective on Turning Up the Immunological Heat on Cancer
- (2019) James W. Opzoomer et al. Frontiers in Immunology
- Glucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System
- (2019) Cindy Strehl et al. Frontiers in Immunology
- Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment
- (2019) Wayne J. Aston et al. OncoImmunology
- Immune Checkpoint Inhibitor Outcomes for Patients With Non–Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications
- (2019) Biagio Ricciuti et al. JOURNAL OF CLINICAL ONCOLOGY
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- More Than Suppression: Glucocorticoid Action on Monocytes and Macrophages
- (2019) Jan M. Ehrchen et al. Frontiers in Immunology
- 966PImpact of corticosteroids on nivolumab activity in metastatic clear cell renal cell carcinoma
- (2019) F Lefort et al. ANNALS OF ONCOLOGY
- Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Peter Schmid et al. LANCET ONCOLOGY
- High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma
- (2018) Alexander T. Faje et al. CANCER
- Macrophage plasticity, polarization, and function in health and disease
- (2018) Abbas Shapouri-Moghaddam et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Brief report: Early use of systemic corticosteroids in patients with advanced NSCLC treated with nivolumab
- (2018) Susan Combs Scott et al. Journal of Thoracic Oncology
- Possible roles for glucocorticoid signalling in breast cancer
- (2018) Keely M. McNamara et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Association of Immune‐Related Adverse Events with Clinical Benefit in Patients with Advanced Non‐Small‐Cell Lung Cancer Treated with Nivolumab
- (2018) Yukihiro Toi et al. ONCOLOGIST
- Regulatory and Mechanistic Actions of Glucocorticoids on T and Inflammatory Cells
- (2018) Ana C. Liberman et al. Frontiers in Endocrinology
- Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
- (2018) Amber J. Giles et al. Journal for ImmunoTherapy of Cancer
- Consequences of long-term OCS therapy and its side effects in severe asthma in adults – A focused review of the impact data in the literature
- (2018) Timm Volmer et al. EUROPEAN RESPIRATORY JOURNAL
- Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer
- (2018) Kathryn C. Arbour et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system
- (2018) Russell Maxwell et al. OncoImmunology
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
- (2018) Moshe Sade-Feldman et al. CELL
- Clinical management of spinal metastases—The Dutch national guideline
- (2018) Laurens Bollen et al. EUROPEAN JOURNAL OF CANCER
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- Non-genomic Effects of Glucocorticoids: An Updated View
- (2018) Reynold A. Panettieri et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis
- (2018) Cheng Xu et al. BMJ-British Medical Journal
- Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma
- (2017) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study
- (2017) Shunsuke Teraoka et al. Journal of Thoracic Oncology
- Management of Metastatic Spinal Cord Compression
- (2017) Quaovi Sodji et al. SOUTHERN MEDICAL JOURNAL
- Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis
- (2017) Peng-Fei Wang et al. Frontiers in Pharmacology
- In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment
- (2017) Guranda Chitadze et al. OncoImmunology
- Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
- (2017) I. Puzanov et al. Journal for ImmunoTherapy of Cancer
- Antibody-Mediated Thyroid Dysfunction During T-cell Checkpoint Blockade in Patients with Non-Small Cell Lung Cancer
- (2016) J.C. Osorio et al. ANNALS OF ONCOLOGY
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Dexamethasone for Dyspnea in Cancer Patients: A Pilot Double-Blind, Randomized, Controlled Trial
- (2016) David Hui et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- New dimension of glucocorticoids in cancer treatment
- (2016) Kai-Ti Lin et al. STEROIDS
- Characterization of nivolumab-associated skin reactions in patients with metastatic non-small cell lung cancer
- (2016) Omar Hasan Ali et al. OncoImmunology
- Effects of Systemically Administered Hydrocortisone on the Human Immunome
- (2016) Matthew J. Olnes et al. Scientific Reports
- Dexamethasone enhances programmed cell death 1 (PD-1) expression during T cell activation: an insight into the optimum application of glucocorticoids in anti-cancer therapy
- (2015) Kailin Xing et al. BMC IMMUNOLOGY
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
- (2015) Lorenzo Galluzzi et al. CANCER CELL
- Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes
- (2015) M. Freeman-Keller et al. CLINICAL CANCER RESEARCH
- GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation
- (2015) Sarah A. Jones et al. JOURNAL OF AUTOIMMUNITY
- Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center
- (2015) Troy Z. Horvat et al. JOURNAL OF CLINICAL ONCOLOGY
- Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial
- (2015) Edward Chow et al. LANCET ONCOLOGY
- Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B
- (2015) Kai-Ti Lin et al. Nature Communications
- Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-M
- (2015) Masanori Miyata et al. Nature Communications
- Survivorship in Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, and Functional Status among Long-term Ipilimumab Survivors at a Single Referral Center
- (2015) Douglas B. Johnson et al. Cancer Immunology Research
- The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis
- (2014) James D. Williamson et al. EXPERIMENTAL LUNG RESEARCH
- Efficacy of Methylprednisolone on Pain, Fatigue, and Appetite Loss in Patients With Advanced Cancer Using Opioids: A Randomized, Placebo-Controlled, Double-Blind Trial
- (2014) Ørnulf Paulsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Bowel Obstruction With Peritoneal Carcinomatosis
- (2014) Guillemette Laval et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Use of Corticosteroids for Anorexia in Palliative Medicine: A Systematic Review
- (2014) Sarah Miller et al. JOURNAL OF PALLIATIVE MEDICINE
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- Role of corticosteroids for fatigue in advanced incurable cancer
- (2014) Sriram Yennurajalingam et al. Current Opinion in Supportive and Palliative Care
- Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab
- (2013) Jeffrey S. Weber et al. CANCER
- Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
- (2013) D. Alizadeh et al. CANCER RESEARCH
- The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting
- (2013) Chin-Chen Chu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
- (2013) Robert H. Oakley et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Interaction of Glucocorticoid Receptor (GR) with Estrogen Receptor (ER) α and Activator Protein 1 (AP1) in Dexamethasone-mediated Interference of ERα Activity
- (2013) Sudipan Karmakar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reduction of Cancer-Related Fatigue With Dexamethasone: A Double-Blind, Randomized, Placebo-Controlled Trial in Patients With Advanced Cancer
- (2013) Sriram Yennurajalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- Dynamic regulatory network controlling TH17 cell differentiation
- (2013) Nir Yosef et al. NATURE
- The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
- (2013) Caroline J. Voskens et al. PLoS One
- The influence of glucocorticoid signaling on tumor progression
- (2012) Paul A. Volden et al. BRAIN BEHAVIOR AND IMMUNITY
- FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells
- (2012) B. Sahu et al. CANCER RESEARCH
- The Role of Corticosteroids in the Treatment of Pain in Cancer Patients
- (2012) Wojciech Leppert et al. Current Pain and Headache Reports
- Treatment of Leptomeningeal Spread of NSCLC: A Continuing Challenge
- (2012) Seema Nagpal et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Dyspnea in Palliative Care: Expanding the Role of Corticosteroids
- (2012) Richard J. Lin et al. JOURNAL OF PALLIATIVE MEDICINE
- Contrary Regulation of Bladder Cancer Cell Proliferation and Invasion by Dexamethasone-Mediated Glucocorticoid Receptor Signals
- (2012) Y. Zheng et al. MOLECULAR CANCER THERAPEUTICS
- Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms
- (2012) M E Law et al. ONCOGENE
- Dexamethasone reduces pain, vomiting and overall complications following tonsillectomy in adults: a systematic review and meta-analysis of randomised controlled trials
- (2011) E.A. Diakos et al. CLINICAL OTOLARYNGOLOGY
- Glucocorticoids inhibit dendritic cell maturation induced by Toll-like receptor 7 and Toll-like receptor 8
- (2011) Alexandre Larangé et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Fatal interstitial lung disease associated with high erlotinib and metabolite levels. A case report and a review of the literature
- (2011) R. ter Heine et al. LUNG CANCER
- Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis
- (2011) Elaine Beaulieu et al. Nature Reviews Rheumatology
- Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy
- (2010) Xin Shelley Wang et al. BRAIN BEHAVIOR AND IMMUNITY
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone
- (2010) Michael P. Gustafson et al. NEURO-ONCOLOGY
- The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline
- (2009) Timothy C. Ryken et al. JOURNAL OF NEURO-ONCOLOGY
- Multiple myeloma
- (2009) Marc S Raab et al. LANCET
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy
- (2008) Bruce D Keith BMC CANCER
- Glucocorticoid receptor expression in breast cancer associates with older patient age
- (2008) Larissa Belova et al. BREAST CANCER RESEARCH AND TREATMENT
- Pulmonary Complications of Novel Antineoplastic Agents for Solid Tumors
- (2008) Bobbak Vahid et al. CHEST
- Dual regulation of glucocorticoid-induced leucine zipper (GILZ) by the glucocorticoid receptor and the PI3-kinase/AKT pathways in multiple myeloma
- (2008) Katharine D. Grugan et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia
- (2008) Pedro J Real et al. NATURE MEDICINE
- The use and toxicity of steroids in the management of patients with brain metastases
- (2008) Alina Sturdza et al. SUPPORTIVE CARE IN CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started